Rituximab treatment circumvents the prognostic impact of tumor-infiltrating T-cells in follicular lymphoma patients-Reference-Cited by-同舟云学术

Rituximab treatment circumvents the prognostic impact of tumor-infiltrating T-cells in follicular lymphoma patients

Published:2017-06 Issue: Volume:64 Page:128-136
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Xerri Luc,Huet Sarah,Venstrom Jeffrey M.,Szafer-Glusman Edith,Fabiani Bettina,Canioni Danielle,Chassagne-Clément Catherine,Dartigues-Cuilléres Peggy,Charlotte Fréderic,Laurent Camille,Gelas-Dore Benedicte,Bolen Christopher R.,Punnoose Elizabeth,Bouabdallah Reda,Brice Pauline,Morschhauser Franck,Cartron Guillaume,Olive Daniel,Salles Gilles

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference35 articles.

1. Survival of patients with non-Hodgkin lymphoma in Germany in the early 21st century;Pulte;Leuk Lymphoma,2013

2. Follicular lymphoma international prognostic index;Solal-Celigny;Blood,2004

3. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry;Pastore;Lancet Oncol,2015

4. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells;Dave;N Engl J Med,2004

5. Follicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transformation;Kiaii;J Clin Oncol,2013

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of positive CD4 cells on event‐free survival in follicular lymphoma patients;Cancer Medicine;2024-09

2. Non-neoplastic cells as prognostic biomarkers in diffuse large B-cell lymphoma: A system review and meta-analysis;Tumori Journal;2024-01-05

3. Long‐term follow‐up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T‐cells in follicular lymphoma patients treated by rituximab‐maintenance regimen;British Journal of Haematology;2023-05-22

4. Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta-analysis;Annals of Hematology;2022-08-27

5. Immune infiltrate diversity confers a good prognosis in follicular lymphoma;Cancer Immunology, Immunotherapy;2021-04-30